## Abstract ## Background Measles is a major cause of childhood morbidity and mortality. Vitamin A deficiency is a recognized risk factor for severe measles infections. The World Health Organization (WHO) recommends administration of an oral dose of vitamin A (200,000 international units (IU), or
Characteristics and key findings for ‘Vitamin A for treating measles in children’
✍ Scribed by Elvira van Dalen; Martin Offringa; Leontien Kremer
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 52 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1557-6272
- DOI
- 10.1002/ebch.60
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
These are the characteristics and key findings for a Cochrane review, published in this issue of EBCH, first published as: Huiming Y, Chaomin W, Meng M. Vitamin A for treating measles in children. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD001479. DOI: 10.1002/14651858.CD001479.pub3.
Further information for this Cochrane review is available in this issue of EBCH in the accompanying EBCH Summary and Expert Commentary articles. Copyright © 2006 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract This is a summary of a Cochrane review, published in this issue of EBCH, first published as: Huiming Y, Chaomin W, Meng M. Vitamin A for treating measles in children. __Cochrane Database of Systematic Reviews__ 2005, Issue 4. Art. No.: CD001479. DOI: 10.1002/14651858.CD001479.pub3. Fur